Medications in the treatment of eating disorders (Q41228989)

28 September 2017

1 reference

title

Medications in the treatment of eating disorders (English)

1 reference

28 September 2017

1 reference

4

Metzger ED

1 reference

28 September 2017

Jimerson DC

1

1 reference

28 September 2017

Wolfe BE

series ordinal

2

1 reference

28 September 2017

Brotman AW

series ordinal

3

1 reference

28 September 2017

publication date

1 December 1996

1 reference

Psychiatric Clinics of North America

28 September 2017

published in

1 reference

28 September 2017

volume

19

1 reference

28 September 2017

issue

4

1 reference

28 September 2017

page(s)

739-754

1 reference

Treatment of bulimia with desipramine: a double-blind crossover study

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Serotonin and appetite

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Serotonin manipulations and the structure of feeding behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Mood- and nutrient-conditioned appetites. Cultural and physiological bases for eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Psychiatric comorbidity in patients with eating disorders1

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Anorexia nervosa. An affective disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

The pathophysiology of anorexia nervosa and bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Hyponatraemia associated with paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A new treatment of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Ipecac myopathy and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Personality disorder and treatment response in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A placebo-controlled trial of d-fenfluramine in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Bulimia nervosa and a stepped care approach to management

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

The use of electroconvulsive therapy in patients with intractable anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Clinical findings in patients with anorexia nervosa and affective illness in their relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Anorexia nervosa 6 years after onset: Part I. Personality disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Hypokalemia in outpatients with eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A double-blind controlled trial of lithium carbonate primary anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Comorbidity of psychiatric diagnoses in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Co-morbidity of eating disorders and substance abuse review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Anorexia nervosa: evidence for a genetic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

The outcome of anorexia nervosa: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

The treatment of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Bulimia nervosa: a four- to six-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Phenomenologic relationship of eating disorders to major affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Treating bulimia with desipramine. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Pharmacologic approaches in the treatment of eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Eating disorders and depression: is there a serotonin connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Psychopharmacological treatment of anorexia nervosa and bulimia. Review and synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Carbamazepine in the treatment of bulimia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Psychiatric disorders in the first-degree relatives of probands with bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Pattern of onset of bulimic symptoms in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

The genetic epidemiology of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Use of L-tryptophan in treating bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

L-tryptophan as an adjunct to treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Bulimia treated with imipramine: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Anorexia nervosa 6 years after onset: Part II. Comorbid psychiatric problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Comorbidity of DSM-III-R eating disorders and personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

The impact of prior substance abuse on treatment outcome for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

A follow-up study of thirty hospitalized bulimics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Affective and anxiety disorders in the long-term follow-up of anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Neuroleptics in the short-term treatment of anorexia nervosa. A double- blind placebo-controlled study with sulpiride

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Phenelzine vs placebo in 50 patients with bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Long-term outcome of antidepressant treatment for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Phenytoin treatment of the binge-eating syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Primary affective disorder in relatives of patients with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Dimensions of response to antidepressant agents in bulimia nervosa: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Impulsivity ratings in bulimia nervosa: relationship to binge eating behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

Screening for Axis II personality disorders in women with bulimic eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970378-6

7 January 2021

10.1016/S0193-953X(05)70378-6

Identifiers

DOI

1 reference

28 September 2017

1 reference